Healthcare
China healthtech funding crashed 49% to $1.92b in H1
China healthtech funding crashed 49% to $1.92b in H1
The number of deals fell to 62 transactions in the same period.
India's healthtech deal value nearly doubled to $355m in H1
Investments in the wellness category ballooned to $155m.
Singapore clinched $145.78m of healthtech deals in 2018
The city trails only behind China and India in terms of deal value.
Asian healthtech deals hit $2.5b
$595m went to firms geared towards health management solutions.
The chatbot will see you now – virtual HCP engagement in the Asia Pacific
There is little doubt that the Asia Pacific region represents a key growth ambition for the majority of Life Sciences companies. Statistics around...
Cell therapy in the Asia Pacific — solution to the cancer challenge?
Over the next decade, an estimated $2t investment into Universal Health Coverage (UHC) schemes is expected to land in Asia. The developing markets in...
IT budgets could shrink for half of life sciences firms
Only 15% of life sciences firms believe digital tools could enhance customer experience.
Cheaper cell therapy gains ground in Australia, China, and Japan
In China, 80% of CAR-T trials are already being conducted by hospitals.
Migrant workers gain access to universal healthcare in Thailand
An estimated 1.5 million undocumented migrants registered with the Ministry of Public Health in 2018.
Top three healthcare firms in Singapore averaged total return at 31.2% in January-July 2019
These three firms’ average dividend yield came at 3.3% over the same period.
Indian drugmakers expand to China through joint ventures: report
Tight competition in the US is driving Indian pharmaceuticals east.
Buyout sought for India's Apollo Hospitals as owner seeks to pay debt
The aim is to reduce the Apollo shares pledged by the controlling family as collateral to lenders, to 20% of their total holding.
Taiwan's health ministry to greenlight cell therapies for two hospitals
Shin Kong International HealthCare Center in Taipei is likely to be approved for non-cancer related cell therapy.
Chinese healthcare revenue growth set to weaken
The plan by the State Council to cut high-value medical consumables prices deals a heavy blow.
Genesis Healthcare launches wellness app
Users can receive lifestyle tips and health recommendations based on individual DNA.
New York-listed New Frontier to buy China's United Family Healthcare for $1.44b
UFH is expected to be given the exclusive right to manage New Frontier Group’s 64,000 sqm flagship Shenzhen city center hospital.
Temasek unit invests $5m in HC Surgical Specialists
It will be done through a 3-year 5.5% convertible bond at a conversion price of $0.54 per share.
Most Read
1. Manulife extends partnership with CUHK Medical Centre 2. Singapore eyes 32 polyclinics by 2030 3. Narayana Health to open 1,100-bed facility in Kolkata, India 4. Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy 5. Gleneagles, Fosun Health partner for enhanced medical integration in GBAResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
PicoSure® Pro takes picosecond laser technology to unprecedented levels of performance.
Commentary
Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy